The safety profile of hormone replacement therapy (HRT) on breast is still controversial. Tibolone is an option of treatment for climacteric syndrome of postmenopausal women. Its risk profile on breast is debated. This is an updated narrative review focusing on the impact of tibolone on breast. Particularly, we will report data from major preclinical and clinical studies regarding the effects of the use of this compound on breast tissue and breast density. Moreover, we will analyze and discuss the most relevant findings of the principal studies evaluating the relationship between tibolone and breast cancer risk. Our purpose is making all clinicians who are particularly involved in women’s health more aware of the effects of this compound on breast and, thus, more experienced in the management of menopausal symptoms with this drug. According to the available literature, tibolone seems to be characterized by an interesting safety profile on breast tissue.

Lello, S., Capozzi, A., Scambia, G., Franceschini, G., Tibolone and Breast Tissue: a Review, <<REPRODUCTIVE SCIENCES>>, 2023; 30 (12): 3403-3409. [doi:10.1007/s43032-023-01295-9] [https://hdl.handle.net/10807/260180]

Tibolone and Breast Tissue: a Review

Capozzi, Antonella;Scambia, Giovanni;Franceschini, Gianluca
2023

Abstract

The safety profile of hormone replacement therapy (HRT) on breast is still controversial. Tibolone is an option of treatment for climacteric syndrome of postmenopausal women. Its risk profile on breast is debated. This is an updated narrative review focusing on the impact of tibolone on breast. Particularly, we will report data from major preclinical and clinical studies regarding the effects of the use of this compound on breast tissue and breast density. Moreover, we will analyze and discuss the most relevant findings of the principal studies evaluating the relationship between tibolone and breast cancer risk. Our purpose is making all clinicians who are particularly involved in women’s health more aware of the effects of this compound on breast and, thus, more experienced in the management of menopausal symptoms with this drug. According to the available literature, tibolone seems to be characterized by an interesting safety profile on breast tissue.
2023
Inglese
Lello, S., Capozzi, A., Scambia, G., Franceschini, G., Tibolone and Breast Tissue: a Review, <<REPRODUCTIVE SCIENCES>>, 2023; 30 (12): 3403-3409. [doi:10.1007/s43032-023-01295-9] [https://hdl.handle.net/10807/260180]
File in questo prodotto:
File Dimensione Formato  
Tibolone and Breast Tissue a Review.pdf

accesso aperto

Licenza: Non specificato
Dimensione 527.37 kB
Formato Adobe PDF
527.37 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/260180
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact